Inhibition of Pathological Increased Matrix Metalloproteinase (MMP) Activity for Improvement of Bone Regeneration in Diabetes
- Supplementary File 1:
ZIP-Document (ZIP, 30 KiB)
Wagner, J.M.; Reinkemeier, F.; Wallner, C.; Dadras, M.; Dittfeld, S.; Drysch, M.; Sogorski, A.; von Glinski, M.; Lehnhardt, M.; Behr, B.; Becerikli, M. Inhibition of Pathological Increased Matrix Metalloproteinase (MMP) Activity for Improvement of Bone Regeneration in Diabetes. Life 2022, 12, 134. https://doi.org/10.3390/life12020134
Wagner JM, Reinkemeier F, Wallner C, Dadras M, Dittfeld S, Drysch M, Sogorski A, von Glinski M, Lehnhardt M, Behr B, Becerikli M. Inhibition of Pathological Increased Matrix Metalloproteinase (MMP) Activity for Improvement of Bone Regeneration in Diabetes. Life. 2022; 12(2):134. https://doi.org/10.3390/life12020134
Chicago/Turabian StyleWagner, Johannes M., Felix Reinkemeier, Christoph Wallner, Mehran Dadras, Stephanie Dittfeld, Marius Drysch, Alexander Sogorski, Maxi von Glinski, Marcus Lehnhardt, Björn Behr, and Mustafa Becerikli. 2022. "Inhibition of Pathological Increased Matrix Metalloproteinase (MMP) Activity for Improvement of Bone Regeneration in Diabetes" Life 12, no. 2: 134. https://doi.org/10.3390/life12020134